Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Indications for Successful Iron Overload Treatments and Monitoring: Hereditary Haemochromatosis
In this webcast, Pierre Brissot, MD, discusses the use of phlebotomy and iron chelation as therapeutic options for the treatment of HFE and non-HFE haemochromatosis. The indications, administration, benefits, and limitations of both these options are addressed.
|
|
Faculty
|
|
|
Pierre Brissot, MD
Professor of Medicine
Liver Disease Department
University Hospital Pontchaillou
Rennes, France
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Assess when to administer phlebotomy or appropriate chelation therapy based on the differences and similarities in HFE and non-HFE haemochromatosis for better management of patients with iron overload.
- Evaluate the benefits and limitations of phlebotomy and iron chelation and know when to use iron chelation as a replacement for, or as an adjunct to, phlebotomy to optimize patient outcomes.
|
Disclosure Information
Pierre Brissot, MD, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation. Prof. Brissot has disclosed that he will not reference any unlabeled/unapproved uses of drugs or devices.
|
|
|
|
|
|
|
